RCSI Serosep partnership (IMAGE)
Caption
Pictured (l-r) are Dr Hannah Fitzgerald, Postdoctoral Researcher, RCSI School of Pharmacy and Biomolecular Sciences; David Clancy, Serosep CTO; and Dr Sudipto Das, Principal Investigator at RCSI School of Pharmacy and Biomolecular Sciences at the announcement of a new partnership between RCSI University of Medicine and Health Sciences and Irish diagnostics company Serosep Ltd which is set to personalise treatment for ulcerative colitis and ultimately improve quality of life for patients with the condition.
Credit
MAXWELLS
Usage Restrictions
None
License
Original content